Size-control of poly(ε-caprolactone) nanospheres by the interface effect of ethanol on the primary emulsion droplets

Journal of Nanoscience and Nanotechnology

Volumn 9, Issue 8, 2009, Pages 4933-4941

  Poletto, Fernanda S ^a,b   Silveira, Rodrigo P ^a   Fiel, Luana A ^b   Donida, Bruna ^a   Rizzi, Marília ^a   Guterres, Sílvia S ^b   Pohlmann, Adriana R ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Emulsification diffusion; Factorial design; Light backscattering; Particle size; Polymeric nanoparticle; Primary emulsion

Indexed keywords

CAPROLACTONE; COMBINED EFFECT; DROPLET SIZES; EMULSION DROPLETS; ETHYL ACETATES; FACTORIAL DESIGN; HYDRODYNAMIC DIAMETER; INTERFACE EFFECT; INTERFACE TENSIONS; LIGHT BACKSCATTERING; MEAN SIZE; MONOMODAL DISTRIBUTION; NANOPARTICLE DIAMETER; ORGANIC PHASE; POLYDISPERSITY INDICES; POLYMERIC NANOPARTICLE; PREDICTIVE MODELS; PRIMARY EMULSION; REGRESSION COEFFICIENT; SIZE-CONTROL; STATISTICAL MODELS; STIRRING RATES;

BACKSCATTERING; DESIGN; DROP FORMATION; EMULSIONS; ESTERS; ETHANOL; FLUID DYNAMICS; NANOPARTICLES; NANOSPHERES; PARTICLE SIZE; PHASE INTERFACES; POLYDISPERSITY; POLYMERS; TITRATION;

EMULSIFICATION;

EID: 70350399625     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2009.1270     Document Type: Article

References (40)

1. E. E. Chiellini, F. Chiellini, and R. Solaro, J. Nanosci. Nanotechnol. 6, 3040 (2006).
2. L. Cruz, S. R. Schaffazick, T. Dalla Costa, L. U. Soares, G. Mezzalira, N. P. da Silveira, E. E. S. Schapoval, A. R. Pohlmann, and S. S. Guterres, J. Nanosci. Nanotechnol. 6, 3154 (2006).
3. F. S. Poletto, E. Jäger, L. Cruz, A. R. Pohlmann, and S. S. Guterres, Mater. Sci. Eng., C 28, 472 (2008).
4. E. Allémann, J.-C. Leroux, and R. Gurny, Adv. Drug Deliv. Rev. 34, 171 (1998).
5. V. Weiss-Angeli, F. S. Poletto, L. R. Zancan, F. Baldasso, A. R. Pohlmann, and S. S. Guterres, J. Biomed. Nanotechnol. 4, 1 (2008).
6. A. Vila, A. Sánchez, M. Tobío, P. Calvo, and M. J. Alonso, J. Control. Release 78, 15 (2002).
7. S. S. Guterres, H. Fessi, G. Barratt, J. P. Devissaguet, and F. Puisieux, Int. J. Pharm. 113, 57 (1995).
8. S. S. Guterres, C. R. Muller, C. B. Michalowski, A. R. Pohlmann, and T. Dalla Costa, S. T. P. Pharm Sci. 11, 229 (2001).
9. E. T. Baran, N. Ozer, and V. Hasirci, J. Mater. Sci.: Mater. Med. 13, 1113 (2002).
10. D. Moinard-Checot, Y. Chevalier, S. Briançon, H. Fessi, and S. Guinebretière, J. Nanosci. Nanotechnol. 6, 2664 (2006).
11. H. Fessi, F. Puisieux, J. P. Devissaguet, N. Ammoury, and S. Benita, Int. J. Pharm. 55, R1 (1989).
12. S. Galindo-Rodriguez, E. Allemann, H. Fessi, and E. Doelker, Pharm. Res. 21, 1428 (2004).
13. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, J. Controlled Release 25, 89 (1993).
14. V. G. Babak, F. Baros, O. Boulanouar, F. Boury, M. Fromm, N. R. Kildeeva, N. Ubrich, and P. Maincent, Colloids Surf., B 59, 194 (2007).
15. D. Quintanar-Guerrero, E. Allemann, E. Doelker, and H. Fessi, Pharm. Res. 15, 1056 (1998).
16. I. Bala, V. Bhardwaj, S. Hariharan, J. Sitterberg, U. Bakowsky, and M. N. V. Ravi Kumar, Nanotechnology 16, 2819 (2005).
17. C. J. Kim, Controlled Release Dosage Form Design, Technomic, Lancaster (2000).
18. Z. M. Miao, S. X. Cheng, X. Z. Zhang, and R. X. Zhuo, Biomacromolecules 7, 2020 (2006).
19. D. Quintanar-Guerrero, H. Fessi, E. Allemann, and E. Doelker, Int. J. Pharm. 143, 133 (1996).
20. U. Bilati, E. Allemann, and E. Doelker, Eur. J. Pharm. Sci. 24, 67 (2005).
21. S. A. Galindo-Rodríguez, F. Puel, S. Briançon, E. Allémann, E. Doelker, and H. Fessi, Eur. J. Pharm. Sci. 25, 357 (2005).
22. D. Quintanar-Guerrero, D. Tamayo-Esquivel, A. Ganem-Quintanar, E. Allemann, and E. Doelker, Eur. J. Pharm. Sci. 26, 211 (2005).
23. Z. Zhang, D. W. Grijpma, and J. Feijen, J. Control. Release 111, 263 (2006).
24. J. A. M. Namur, E. C. D. Cabral-Albuquerque, W. Quintilio, M. H. A. de Santana, M. J. Politi, P. S. de Araujo, A. C. Lopes, and M. H. B. da Costa, J. Nanosci. Nanotechnol. 6, 2403 (2006).
25. S. W. Choi, H. Y. Kwon, W. S. Kim, and J. H. Kim, Colloids Surf., A 201, 283 (2002).
26. H. Murakami, M. Kobayashi, H. Takeuchi, and Y. Kawashima, Int. J. Pharm. 187, 143 (1999).
27. O. Mertins, M. B. Cardoso, A. R. Pohlmann, and N. P. da Silveira, J. Nanosci. Nanotechnol. 6, 2425 (2006).
28. A. R. Pohlmann, L. U. Soares, L. Cruz, N. P. da Silveira, and S. S. Guterres, Curr. Drug Deliv. 1, 103 (2004).
29. L. Cruz, L. U. Soares, T. Dalla Costa, G. Mezzalira, N. P. da Silveira, S. S. Guterres, and A. R. Pohlmann, Int. J. Pharm. 313, 198 (2006).
30. A. Jäger, V. Stefani, S. S. Guterres, and A. R. Pohlmann, Int. J. Pharm. 338, 297 (2007).
31. F. S. Poletto, L. A. Fiel, B. Donida, M. I. Ré. S. S. Guterres, and A. R. Pohlmann, Colloids Surf., A 324, 105 (2008).
32. M. C. Julienne, M. J. Alonso, J. L. G. Amoza, and J. P. Benoit, Drug Dev. Ind. Pharm. 18, 1063 (1992).
33. O. Mengual, G. Meunier, I. Cayre, K. Puech, and P. Snabre, Colloids Surf., A 152, 111 (1999).
34. O. Mengual, G. Meunier, I. Cayre, K. Peuch, and P. Snabre, Talanta 50, 445 (1999).
35. M. C. Ruiz, P. Lermanda, and R. Padilla, Hydrometallurgy 63, 65 (2002).
36. A. Budhian, S. J. Siegel, and K. I. Winey, Int. J. Pharm. 336, 367 (2007).
37. R. M. Mainardes and R. C. Evangelista, Int. J. Pharm. 290, 137 (2005).
38. H. Y. Kwon, J. Y. Lee, S. W. Choi, Y. Jang, and J. H. Kim, Colloids Surf. A 182, 123 (2001).
39. R. Jiang, H. A. E. Benson, S. E. Cross, and M. S. Roberts, Pharm. Res. 15, 1863 (1998).
40. M. O'Brien, J. McCauley, E. Cohen, and E. Indomethacin, edited by K. Florey, Analytical Profiles of Drug Substances, Academic Press, New York (1984), Vol. 13, pp. 211-218.